Products Categories
CAS No.: | 55985-32-5 |
---|---|
Name: | Nicardipine |
Article Data: | 13 |
Molecular Structure: | |
Formula: | C26H29 N3 O6 |
Molecular Weight: | 479.533 |
Synonyms: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl2-[methyl(phenylmethyl)amino]ethyl ester (9CI); (?à)-Nicardipine; Nicardipine; Perpidine |
EINECS: | 259-932-3 |
Density: | 1.23 g/cm3 |
Melting Point: | 136-138 ºC |
Boiling Point: | 603.4 °C at 760 mmHg |
Flash Point: | 318.7 °C |
PSA: | 113.69000 |
LogP: | 4.52980 |
2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-methyl ester 5-[2-(toluene-4-sulfonyloxy)-ethyl] ester
benzyl-methyl-amine
Nicardipine
Conditions | Yield |
---|---|
for 8h; Heating; | 77% |
Conditions | Yield |
---|---|
With potassium hydroxide In tetrahydrofuran at 25℃; for 24h; | 67% |
Conditions | Yield |
---|---|
With potassium hydroxide In tetrahydrofuran at 25℃; | 32% |
Conditions | Yield |
---|---|
With potassium hydroxide In tetrahydrofuran at 25℃; | 26% |
Nicardipine
Conditions | Yield |
---|---|
With sodium methylate In isopropyl alcohol Heating; |
Nicardipine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 93 percent / CHCl3 / Heating 2: 67 percent / KOH / tetrahydrofuran / 24 h / 25 °C View Scheme | |
Multi-step reaction with 2 steps 1: 95 percent / CHCl3 / Heating 2: 26 percent / KOH / tetrahydrofuran / 25 °C View Scheme | |
Multi-step reaction with 2 steps 1: 94 percent / acetone / 8 h / Heating 2: 32 percent / KOH / tetrahydrofuran / 25 °C View Scheme |
3-nitrooxypropyl acetoacetate
Nicardipine
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 38 percent / piperidine / benzene / 11 h / Heating 2: 30 percent / sodium methoxide / propan-2-ol / Heating 3: sodium methoxide / propan-2-ol / Heating View Scheme |
3-nitroxypropyl 2-(3-cyanobenzylidene)acetoacetate
Nicardipine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 30 percent / sodium methoxide / propan-2-ol / Heating 2: sodium methoxide / propan-2-ol / Heating View Scheme |
2-hydroxyethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
Nicardipine
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 100 percent / 1.) Et3N; 2.) H2O / tetrahydrofuran / 1.) 1 h; 2.) 0.5 h 2: 77 percent / 8 h / Heating View Scheme |
Nicardipine
IUPAC Name: 3-O-[2-[benzyl(methyl)amino]ethyl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Synonyms Methyl 2-(benzyl-methyl-amino)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Product Categories: Active Pharmaceutical Ingredients
Molecular Structure: m-nitrobenzaldehyde as raw materials, condensation of acetyl chloride acid methyl ester with the amino-crotonic to get 2,6 - dimethyl -4 - (Inter-nitrophenyl) -1,4 - dihydro-pyridine 3,5 - 2-carboxylic acid - (2 - chloro) ethyl -5 - methyl ester, then condensation with benzyl amine nicardipine.
Molecular Formula: C26H29N3O6
Molecular Weight : 479.52
CAS NO: 55985-32-5
EINECS : 259-932-3
Mol File: 55985-32-5.mol
Melting point 136-138 ºC
Index of Refraction: 1.581
Surface Tension: 48.7 dyne/cm
Density: 1.23 g/cm3
Flash Point: 318.7 °C
Enthalpy of Vaporization: 89.75 kJ/mol
Boiling Point: 603.4 °C at 760 mmHg
Vapour Pressure: 1.63E-14 mmHg at 25°C
Appearance: Nicardipine Hydrochloride (CAS NO.55985-32-5) is yellow-green crystalline powder.
Nicardipine Hydrochloride (CAS NO.55985-32-5) is a new calcium antagonist, vasodilator,mainly used for ischemic cerebrovascular disease and the treatment of essential hypertension.
M-Nitrobenzaldehyde as raw materials, condensation of acetyl chloride acid methyl ester with the amino-crotonic to get 2,6 - dimethyl -4 - (Inter-nitrophenyl) -1,4 - dihydro-pyridine 3,5 - 2-carboxylic acid - (2 - chloro) ethyl -5 - methyl ester, then condensation with benzyl amine nicardipine. Get Nicardipine Hydrochloride (CAS NO.55985-32-5) .
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | oral | 1250ug/kg (1.25mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING | American Journal of Emergency Medicine. Vol. 18, Pg. 581, 2000. |
mouse | LD50 | intravenous | 9700ug/kg (9.7mg/kg) | United States Patent Document. Vol. #4672068, | |
mouse | LD50 | oral | 305mg/kg (305mg/kg) | United States Patent Document. Vol. #4824855, | |
rat | LD50 | intravenous | 11800ug/kg (11.8mg/kg) | United States Patent Document. Vol. #4710505, | |
rat | LD50 | oral | 320mg/kg (320mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 35, Pg. 915, 1985. |